
更新時間: 2026-11-20 10:30:33
Insmed Incorporated 是一家生物製藥公司,致力於為患有罕見且嚴重疾病的患者開發與銷售療法。該公司總部位於新澤西州布里奇沃特。
| 指標 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 收入 | $425.486M | $305.964M | $263.843M | $142.342M |
| 經營支出 | $67.212M | $49.501M | $44.22M | $29.365M |
| 淨收入 | -$13.242M | -$163.563M | -$328.485M | -$370.021M |
| 淨利率 | -3.1% | -53.5% | -124.5% | -260.0% |
| 每股收益 | -- | $-0.76 | $-1.54 | $-1.75 |
| 息稅折舊攤銷前利潤 | $14.16M | -$136.323M | -$302.15M | -$345.665M |
| 有效稅率 | -16.4% | -0.9% | -0.5% | -0.4% |